Weiwei Zhu Selected Research

Weiwei Zhu Research Topics

Disease

30	Neoplasms (Cancer) 04/2024 - 04/2009
19	Inflammation (Inflammations) 01/2024 - 04/2016
11	Fibrosis (Cirrhosis) 04/2024 - 01/2018
10	Breast Neoplasms (Breast Cancer) 01/2023 - 05/2012
7	Carcinogenesis 01/2023 - 02/2011
6	Diabetic Cardiomyopathies 03/2024 - 01/2019
5	Acute Lung Injury 04/2024 - 01/2018
5	Hypertrophy 03/2024 - 06/2019
5	Acute Kidney Injury (Acute Renal Failure) 02/2024 - 01/2018
5	Sepsis (Septicemia) 11/2023 - 01/2018
5	Lung Neoplasms (Lung Cancer) 01/2023 - 08/2015
5	Melanoma (Melanoma, Malignant) 01/2022 - 09/2009
5	Insulin Resistance 03/2021 - 04/2016
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2023 - 06/2019
4	Obesity 01/2023 - 04/2017
4	Infections 01/2022 - 03/2016
3	Non-alcoholic Fatty Liver Disease 02/2023 - 11/2021
3	Pathologic Constriction (Stenosis) 12/2022 - 10/2006
3	Atrial Fibrillation 11/2022 - 10/2019
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2022 - 01/2020
3	Thrombosis (Thrombus) 07/2022 - 12/2017
3	Carcinoma (Carcinomatosis) 01/2022 - 07/2009
3	Virus Diseases (Viral Diseases) 03/2021 - 06/2013
3	Prostatic Neoplasms (Prostate Cancer) 02/2019 - 09/2010
3	Gestational Diabetes (Gestational Diabetes Mellitus) 06/2018 - 01/2016
2	Body Weight (Weight, Body) 03/2024 - 01/2017
2	Type 2 Diabetes Mellitus (MODY) 12/2023 - 10/2022
2	Asthma (Bronchial Asthma) 11/2023 - 02/2015
2	Cardiomyopathies (Cardiomyopathy) 11/2023 - 01/2023
2	Multiple Myeloma 02/2023 - 04/2014
2	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 01/2018
2	Lung Injury 01/2023 - 01/2019
2	Stomach Neoplasms (Stomach Cancer) 01/2023 - 10/2015
2	Autoimmune Diseases (Autoimmune Disease) 07/2022 - 04/2016
2	Human Influenza (Influenza) 01/2022 - 11/2019
2	Osteoarthritis 01/2022 - 12/2019
2	Death (Near-Death Experience) 01/2022 - 01/2020
2	Septic Shock (Toxic Shock Syndrome) 11/2021 - 01/2018
2	Disseminated Intravascular Coagulation 11/2021 - 02/2020
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2021 - 11/2020
2	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2021 - 01/2016
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021 - 11/2018
2	Neoplasm Metastasis (Metastasis) 03/2020 - 01/2019

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 06/2023 - 04/2012
11	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2012
10	CurcuminIBA 03/2024 - 01/2012
9	Glucose (Dextrose)FDA LinkGeneric 12/2023 - 04/2013
7	CytokinesIBA 01/2023 - 06/2013
6	LipopolysaccharidesIBA 04/2024 - 01/2016
5	Streptozocin (Streptozotocin)FDA Link 03/2024 - 10/2022
5	Mitogen-Activated Protein KinasesIBA 02/2023 - 10/2015
5	MicroRNAs (MicroRNA)IBA 01/2023 - 10/2014
5	Antiviral Agents (Antivirals)IBA 11/2019 - 06/2013
5	SmokeIBA 01/2018 - 01/2015
4	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 07/2014
4	ErbB Receptors (EGF Receptor)IBA 11/2023 - 02/2022
4	Therapeutic UsesIBA 02/2023 - 04/2016
4	LipidsIBA 02/2023 - 01/2016
4	Hormones (Hormone)IBA 02/2022 - 06/2012
4	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2021 - 06/2013
4	LigandsIBA 01/2020 - 09/2010
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2019 - 09/2009
3	InflammasomesIBA 11/2023 - 01/2019
3	Palmitic Acid (Hexadecanoic Acid)IBA 11/2023 - 11/2021
3	OvalbuminIBA 11/2023 - 08/2013
3	Long Noncoding RNAIBA 01/2023 - 10/2019
3	Syndecan-1 (Syndecan 1)IBA 01/2022 - 02/2020
3	Messenger RNA (mRNA)IBA 01/2022 - 01/2018
3	EnzymesIBA 01/2020 - 01/2017
3	4-boronic acid benzophenoneIBA 02/2019 - 10/2018
3	butylbenzyl phthalate (benzyl butyl phthalate)IBA 02/2019 - 10/2018
3	Insulin (Novolin)FDA Link 01/2018 - 04/2016
3	Toll-Like Receptor 3IBA 07/2015 - 06/2013
2	3-(2,4-dimethoxybenzylidene)anabaseineIBA 04/2024 - 02/2024
2	Antidepressive Agents (Antidepressants)IBA 01/2024 - 01/2022
2	Interleukin-18 (Interleukin 18)IBA 11/2023 - 07/2019
2	EndotoxinsIBA 11/2023 - 01/2019
2	CaspasesIBA 11/2023 - 02/2011
2	Tyrosine Kinase InhibitorsIBA 11/2023 - 09/2023
2	GTP Phosphohydrolases (GTPases)IBA 11/2023 - 02/2015
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 09/2023 - 04/2012
2	Monoclonal AntibodiesIBA 09/2023 - 11/2022
2	nimotuzumabIBA 09/2023 - 11/2022
2	PalmitatesIBA 01/2023 - 01/2018
2	VaccinesIBA 01/2023 - 09/2009
2	TeaIBA 11/2022 - 01/2019
2	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2022 - 03/2016
2	IodineIBA 01/2022 - 10/2019
2	Hyaluronic Acid (Hyaluronan)IBA 01/2022 - 11/2021
2	p38 Mitogen-Activated Protein KinasesIBA 01/2022 - 04/2016
2	Heparitin Sulfate (Heparan Sulfate)IBA 01/2022 - 11/2021
2	Chimeric Antigen ReceptorsIBA 04/2021 - 11/2020
2	TitaniumIBA 01/2021 - 01/2020
2	Heparin (Liquaemin)FDA LinkGeneric 02/2020 - 12/2017

Therapy/Procedure

15	Therapeutics 09/2023 - 06/2012
3	Radiotherapy 10/2021 - 01/2019
3	Chemoprevention 08/2017 - 01/2015
2	Precision Medicine 04/2024 - 03/2024
2	Catheter Ablation 11/2022 - 10/2019
2	Segmental Mastectomy (Lumpectomy) 03/2020 - 01/2018